Acinetobacter baumannii

References

• Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, et al. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit Care Nurse 2008; 28:15 - 25, quiz 26; PMID: 18238934
   PubMed Web of Science ®Google Scholar
• Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT, Fishbain J, et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol 2006; 44:2630 - 4; http://dx.doi.org/10.1128/JCM.00547-06; PMID: 16825400
   PubMed Web of Science ®Google Scholar
• Sebeny PJ, Riddle MS, Petersen K. Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. Clin Infect Dis 2008; 47:444 - 9; http://dx.doi.org/10.1086/590568; PMID: 18611157
   PubMed Web of Science ®Google Scholar
• Cerqueira GM, Peleg AY. Insights into Acinetobacter baumannii pathogenicity. IUBMB Life 2011; 63:1055 - 60; http://dx.doi.org/10.1002/iub.533; PMID: 21989983
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538 - 82; http://dx.doi.org/10.1128/CMR.00058-07; PMID: 18625687
   PubMed Web of Science ®Google Scholar
• Bassetti M, Ginocchio F, Mikulska M. New treatment options against gram-negative organisms. Crit Care 2011; 15:215; http://dx.doi.org/10.1186/cc9997; PMID: 21457501
   PubMed Web of Science ®Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197:1079 - 81; http://dx.doi.org/10.1086/533452; PMID: 18419525
   PubMed Web of Science ®Google Scholar
• Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006; 2:e7; http://dx.doi.org/10.1371/journal.pgen.0020007; PMID: 16415984
   PubMed Web of Science ®Google Scholar
• CDC. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004 (Reprinted from MMWR, vol 53, pg 1063-1066, 2004). JAMA 2004; 292:2964 - 6; http://dx.doi.org/10.1001/jama.292.24.2964
   Web of Science ®Google Scholar
• Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9:148 - 65; PMID: 8964033
   PubMed Web of Science ®Google Scholar
• Beijerinck MW. Über Pigmentbildung bei Essigbakterien. Centr Bakteriol Parasitenk Abt 1911:167-76.
   Google Scholar
• Brisou J, Prevot AR. [Studies on bacterial taxonomy. X. The revision of species under Acromobacter group]. Ann Inst Pasteur (Paris) 1954; 86:722 - 8; PMID: 13197842
   PubMedGoogle Scholar
• Baumann P, Doudoroff M, Stanier RY. A study of the Moraxella group. II. Oxidative-negative species (genus Acinetobacter). J Bacteriol 1968; 95:1520 - 41; PMID: 5650064
   PubMed Web of Science ®Google Scholar
• Lessel EF. International Committee on Nomenclature of Bacteria Subcommittee on the Taxonomy of Moraxella and Allied Bacteria: Minutes of the Meeting, 11 August 1970. Room Constitution C, Maria-Isabel Hotel, Mexico City, Mexico. Int J Syst Bacteriol 1971; 21:213 - 4; http://dx.doi.org/10.1099/00207713-21-2-213
   Google Scholar
• Di Nocera PP, Rocco F, Giannouli M, Triassi M, Zarrilli R. Genome organization of epidemic Acinetobacter baumannii strains. BMC Microbiol 2011; 11:224; http://dx.doi.org/10.1186/1471-2180-11-224; PMID: 21985032
   PubMed Web of Science ®Google Scholar
• Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 1991; 29:277 - 82; PMID: 2007635
   PubMed Web of Science ®Google Scholar
• Juni E. Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus. J Bacteriol 1972; 112:917 - 31; PMID: 4563985
   PubMed Web of Science ®Google Scholar
• Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997; 35:2819 - 25; PMID: 9350741
   PubMed Web of Science ®Google Scholar
• Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G, et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 1995; 33:11 - 5; PMID: 7699025
   PubMed Web of Science ®Google Scholar
• Janssen P, Maquelin K, Coopman R, Tjernberg I, Bouvet P, Kersters K, et al. Discrimination of Acinetobacter genomic species by AFLP fingerprinting. Int J Syst Bacteriol 1997; 47:1179 - 87; http://dx.doi.org/10.1099/00207713-47-4-1179; PMID: 9336926
   PubMedGoogle Scholar
• Gerner-Smidt P. Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Clin Microbiol 1992; 30:2680 - 5; PMID: 1383266
   PubMed Web of Science ®Google Scholar
• Ehrenstein B, Bernards AT, Dijkshoorn L, Gerner-Smidt P, Towner KJ, Bouvet PJ, et al. Acinetobacter species identification by using tRNA spacer fingerprinting. J Clin Microbiol 1996; 34:2414 - 20; PMID: 8880491
   PubMed Web of Science ®Google Scholar
• Dolzani L, Tonin E, Lagatolla C, Prandin L, Monti-Bragadin C. Identification of Acinetobacter isolates in the A. calcoaceticus-A. baumannii complex by restriction analysis of the 16S-23S rRNA intergenic-spacer sequences. J Clin Microbiol 1995; 33:1108 - 13; PMID: 7542263
   PubMed Web of Science ®Google Scholar
• Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005; 43:1632 - 9; http://dx.doi.org/10.1128/JCM.43.4.1632-1639.2005; PMID: 15814977
   PubMed Web of Science ®Google Scholar
• La Scola B, Raoult D. Acinetobacter baumannii in human body louse. Emerg Infect Dis 2004; 10:1671 - 3; PMID: 15498175
   PubMed Web of Science ®Google Scholar
• Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42:692 - 9; http://dx.doi.org/10.1086/500202; PMID: 16447117
   PubMed Web of Science ®Google Scholar
• Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT, Fishbain J, et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol 2006; 44:2630 - 4; http://dx.doi.org/10.1128/JCM.00547-06; PMID: 16825400
   PubMed Web of Science ®Google Scholar
• Gootz TD, Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti Infect Ther 2008; 6:309 - 25; http://dx.doi.org/10.1586/14787210.6.3.309; PMID: 18588496
   PubMed Web of Science ®Google Scholar
• Bayuga S, Zeana C, Sahni J, Della-Latta P, el-Sadr W, Larson E. Prevalence and antimicrobial patterns of Acinetobacter baumannii on hands and nares of hospital personnel and patients: the iceberg phenomenon again. Heart Lung 2002; 31:382 - 90; http://dx.doi.org/10.1067/mhl.2002.126103; PMID: 12487017
   PubMed Web of Science ®Google Scholar
• Gusten WM, Hansen EA, Cunha BA. Acinetobacter baumannii pseudomeningitis. Heart Lung 2002; 31:76 - 8; http://dx.doi.org/10.1067/mhl.2002.120258; PMID: 11805753
   PubMed Web of Science ®Google Scholar
• Lorente C, Del Castillo Y, Rello J. Prevention of infection in the intensive care unit: current advances and opportunities for the future. Curr Opin Crit Care 2002; 8:461 - 4; http://dx.doi.org/10.1097/00075198-200210000-00015; PMID: 12357116
   PubMedGoogle Scholar
• Choi CH, Lee EY, Lee YC, Park TI, Kim HJ, Hyun SH, et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol 2005; 7:1127 - 38; http://dx.doi.org/10.1111/j.1462-5822.2005.00538.x; PMID: 16008580
   PubMed Web of Science ®Google Scholar
• Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 2009; 4:273 - 8; http://dx.doi.org/10.2217/fmb.09.5; PMID: 19327114
   PubMed Web of Science ®Google Scholar
• Kim SW, Choi CH, Moon DC, Jin JS, Lee JH, Shin JH, et al. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett 2009; 301:224 - 31; http://dx.doi.org/10.1111/j.1574-6968.2009.01820.x; PMID: 19878322
   PubMed Web of Science ®Google Scholar
• Jacobs AC, Hood I, Boyd KL, Olson PD, Morrison JM, Carson S, et al. Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect Immun 2010; 78:1952 - 62; http://dx.doi.org/10.1128/IAI.00889-09; PMID: 20194595
   PubMed Web of Science ®Google Scholar
• Camarena L, Bruno V, Euskirchen G, Poggio S, Snyder M. Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing. PLoS Pathog 2010; 6:e1000834; http://dx.doi.org/10.1371/journal.ppat.1000834; PMID: 20368969
   PubMed Web of Science ®Google Scholar
• Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003; 41:3542 - 7; http://dx.doi.org/10.1128/JCM.41.8.3542-3547.2003; PMID: 12904353
   PubMed Web of Science ®Google Scholar
• Hujer KM, Hamza NS, Hujer AM, Perez F, Helfand MS, Bethel CR, et al. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother 2005; 49:2941 - 8; http://dx.doi.org/10.1128/AAC.49.7.2941-2948.2005; PMID: 15980372
   PubMed Web of Science ®Google Scholar
• Corvec S, Caroff N, Espaze E, Giraudeau C, Drugeon H, Reynaud A. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother 2003; 52:629 - 35; http://dx.doi.org/10.1093/jac/dkg407; PMID: 12951337
   PubMed Web of Science ®Google Scholar
• Alsultan AA, Hamouda A, Evans BA, Amyes SG. Acinetobacter baumannii: emergence of four strains with novel bla(OXA-51-like) genes in patients with diabetes mellitus. J Chemother 2009; 21:290 - 5; PMID: 19567349
   PubMed Web of Science ®Google Scholar
• Turton JF, Kaufmann ME, Warner M, Coelho J, Dijkshoorn L, van der Reijden T, et al. A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 2004; 58:170 - 9; http://dx.doi.org/10.1016/j.jhin.2004.05.011; PMID: 15501330
   PubMed Web of Science ®Google Scholar
• Schulte B, Goerke C, Weyrich P, Gröbner S, Bahrs C, Wolz C, et al. Clonal spread of meropenem-resistant Acinetobacter baumannii strains in hospitals in the Mediterranean region and transmission to South-west Germany. J Hosp Infect 2005; 61:356 - 7; http://dx.doi.org/10.1016/j.jhin.2005.05.009; PMID: 16213625
   PubMed Web of Science ®Google Scholar
• Unal S, Garcia-Rodriguez JA. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004. Diagn Microbiol Infect Dis 2005; 53:265 - 71; http://dx.doi.org/10.1016/j.diagmicrobio.2005.10.002; PMID: 16360550
   PubMed Web of Science ®Google Scholar
• Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N, et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994; 344:1329 - 32; http://dx.doi.org/10.1016/S0140-6736(94)90694-7; PMID: 7968028
   PubMed Web of Science ®Google Scholar
• Rahal JJUC, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280:1233 - 7; http://dx.doi.org/10.1001/jama.280.14.1233; PMID: 9786372
   PubMed Web of Science ®Google Scholar
• Halstead DC, Abid J, Dowzicky MJ. Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial. J Infect 2007; 55:49 - 57; http://dx.doi.org/10.1016/j.jinf.2006.11.018; PMID: 17250897
   PubMed Web of Science ®Google Scholar
• Gales AC, Jones RN, Sader HS. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 2006; 12:315 - 21; http://dx.doi.org/10.1111/j.1469-0691.2005.01351.x; PMID: 16524407
   PubMed Web of Science ®Google Scholar
• Ko KS, Suh JY, Kwon KT, Jung SI, Park KH, Kang CI, et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007; 60:1163 - 7; http://dx.doi.org/10.1093/jac/dkm305; PMID: 17761499
   PubMed Web of Science ®Google Scholar
• Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 2010; 35:219 - 26; http://dx.doi.org/10.1016/j.ijantimicag.2009.10.024; PMID: 20047818
   PubMed Web of Science ®Google Scholar
• Grupper M, Sprecher H, Mashiach T, Finkelstein R. Attributable mortality of nosocomial Acinetobacter bacteremia. Infect Control Hosp Epidemiol 2007; 28:293 - 8; http://dx.doi.org/10.1086/512629; PMID: 17326019
   PubMed Web of Science ®Google Scholar
• Lee NY, Lee HC, Ko NY, Chang CM, Shih HI, Wu CJ, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007; 28:713 - 9; http://dx.doi.org/10.1086/517954; PMID: 17520546
   PubMed Web of Science ®Google Scholar
• Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007; 13:97 - 103; http://dx.doi.org/10.3201/eid1301.060716; PMID: 17370521
   PubMed Web of Science ®Google Scholar
• Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect 2009; 73:143 - 50; http://dx.doi.org/10.1016/j.jhin.2009.06.007; PMID: 19716203
   PubMed Web of Science ®Google Scholar
• Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007; 44:1577 - 84; http://dx.doi.org/10.1086/518170; PMID: 17516401
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Ortiz-Leyba C, Ferńndez-Hinojosa E, Aldabó-Pallás T, Cayuela A, Marquez-Vácaro JA, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005; 31:649 - 55; http://dx.doi.org/10.1007/s00134-005-2598-0; PMID: 15785929
   PubMed Web of Science ®Google Scholar
• Luna CM, Aruj PK. Nosocomial Acinetobacter pneumonia. Respirology 2007; 12:787 - 91; http://dx.doi.org/10.1111/j.1440-1843.2007.01147.x; PMID: 17986104
   PubMed Web of Science ®Google Scholar
• Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 2002; 40:685 - 6; http://dx.doi.org/10.1128/JCM.40.2.685-686.2002; PMID: 11825997
   PubMed Web of Science ®Google Scholar
• Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 2006; 129:102 - 9; http://dx.doi.org/10.1378/chest.129.1.102; PMID: 16424419
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309 - 17; http://dx.doi.org/10.1086/421946; PMID: 15306996
   PubMed Web of Science ®Google Scholar
• Trottier V, Segura PG, Namias N, King D, Pizano LR, Schulman CI. Outcomes of Acinetobacter baumannii infection in critically ill burned patients. J Burn Care Res 2007; 28:248 - 54; http://dx.doi.org/10.1097/BCR.0B013E318031A20F; PMID: 17351441
   PubMed Web of Science ®Google Scholar
• Gaynes R, Edwards JR, National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005; 41:848 - 54; http://dx.doi.org/10.1086/432803; PMID: 16107985
   PubMed Web of Science ®Google Scholar
• Briggs S, Ellis-Pegler R, Raymond N, Thomas M, Wilkinson L. Gram-negative bacillary meningitis after cranial surgery or trauma in adults. Scand J Infect Dis 2004; 36:165 - 73; http://dx.doi.org/10.1080/00365540410027193; PMID: 15119359
   PubMed Web of Science ®Google Scholar
• Metan G, Alp E, Aygen B, Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother 2007; 60:197 - 9; http://dx.doi.org/10.1093/jac/dkm181; PMID: 17540668
   PubMed Web of Science ®Google Scholar
• Kwon KT, Oh WS, Song JH, Chang HH, Jung SI, Kim SW, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007; 59:525 - 30; http://dx.doi.org/10.1093/jac/dkl499; PMID: 17213265
   PubMed Web of Science ®Google Scholar
• Shankar R, He LK, Szilagyi A, Muthu K, Gamelli RL, Filutowicz M, et al. A novel antibacterial gene transfer treatment for multidrug-resistant Acinetobacter baumannii-induced burn sepsis. J Burn Care Res 2007; 28:6 - 12; http://dx.doi.org/10.1097/BCR.0b013e31802c8861; PMID: 17211194
   PubMed Web of Science ®Google Scholar
• Mihu MR, Martinez LR. Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections. Virulence 2011; 2:97 - 102; http://dx.doi.org/10.4161/viru.2.2.15061; PMID: 21321482
   PubMed Web of Science ®Google Scholar
• Coates AR, Hu Y. Novel approaches to developing new antibiotics for bacterial infections. Br J Pharmacol 2007; 152:1147 - 54; http://dx.doi.org/10.1038/sj.bjp.0707432; PMID: 17704820
   PubMed Web of Science ®Google Scholar
• Poole K. Overcoming multidrug resistance in gram-negative bacteria. Curr Opin Investig Drugs 2003; 4:128 - 39; PMID: 12669372
   PubMedGoogle Scholar
• Yang H, Liang L, Lin S, Jia S. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol 2010; 10:131; http://dx.doi.org/10.1186/1471-2180-10-131; PMID: 20426877
   PubMed Web of Science ®Google Scholar
• Wang J, Wong ES, Whitley JC, Li J, Stringer JM, Short KR, et al. Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options. PLoS One 2011; 6:e24030; http://dx.doi.org/10.1371/journal.pone.0024030; PMID: 21912615
   PubMed Web of Science ®Google Scholar
• Hancock REW, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006; 24:1551 - 7; http://dx.doi.org/10.1038/nbt1267; PMID: 17160061
   PubMed Web of Science ®Google Scholar
• Lisanby MW, Swiecki MK, Dizon BL, Pflughoeft KJ, Koehler TM, Kearney JF. Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol 2008; 181:4989 - 5000; PMID: 18802102
   PubMed Web of Science ®Google Scholar
• Dadachova E, Burns T, Bryan RA, Apostolidis C, Brechbiel MW, Nosanchuk JD, et al. Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrob Agents Chemother 2004; 48:1624 - 9; http://dx.doi.org/10.1128/AAC.48.5.1624-1629.2004; PMID: 15105113
   PubMed Web of Science ®Google Scholar
• Dadachova E, Nakouzi A, Bryan RA, Casadevall A. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A 2003; 100:10942 - 7; http://dx.doi.org/10.1073/pnas.1731272100; PMID: 12930899
   PubMed Web of Science ®Google Scholar
• Dadachova E, Patel MC, Toussi S, Apostolidis C, Morgenstern A, Brechbiel MW, et al. Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med 2006; 3:e427; http://dx.doi.org/10.1371/journal.pmed.0030427; PMID: 17090209
   PubMed Web of Science ®Google Scholar
• McConnell MJ, Domínguez-Herrera J, Smani Y, López-Rojas R, Docobo-Pérez F, Pachón J. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect Immun 2011; 79:518 - 26; http://dx.doi.org/10.1128/IAI.00741-10; PMID: 20974823
   PubMed Web of Science ®Google Scholar
• Islam AH, Singh KK, Ismail A. Demonstration of an outer membrane protein that is antigenically specific for Acinetobacter baumannii. Diagn Microbiol Infect Dis 2011; 69:38 - 44; http://dx.doi.org/10.1016/j.diagmicrobio.2010.09.008; PMID: 21146712
   PubMed Web of Science ®Google Scholar
• Castano AP, Mroz P, Wu MX, Hamblin MR. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci U S A 2008; 105:5495 - 500; http://dx.doi.org/10.1073/pnas.0709256105; PMID: 18378905
   PubMed Web of Science ®Google Scholar
• Demidova TN, Hamblin MR. Photodynamic therapy targeted to pathogens. Int J Immunopathol Pharmacol 2004; 17:245 - 54; PMID: 15461858
   PubMed Web of Science ®Google Scholar
• Dai T, Tegos GP, Lu Z, Huang L, Zhiyentayev T, Franklin MJ, et al. Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother 2009; 53:3929 - 34; http://dx.doi.org/10.1128/AAC.00027-09; PMID: 19564369
   PubMed Web of Science ®Google Scholar
• Tsai T, Chien HF, Wang TH, Huang CT, Ker YB, Chen CT. Chitosan augments photodynamic inactivation of gram-positive and gram-negative bacteria. Antimicrob Agents Chemother 2011; 55:1883 - 90; http://dx.doi.org/10.1128/AAC.00550-10; PMID: 21282440
   PubMed Web of Science ®Google Scholar
• Mowbray M, Tan XJ, Wheatley PS, Rossi AG, Morris RE, Weller RB. Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation. J Invest Dermatol 2008; 128:352 - 60; http://dx.doi.org/10.1038/sj.jid.5701096; PMID: 17914444
   PubMed Web of Science ®Google Scholar
• Soneja A, Drews M, Malinski T. Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep 2005; 57:Suppl 108 - 19; PMID: 16415491
   PubMed Web of Science ®Google Scholar
• Friedman AJ, Han G, Navati MS, Chacko M, Gunther L, Alfieri A, et al. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 2008; 19:12 - 20; http://dx.doi.org/10.1016/j.niox.2008.04.003; PMID: 18457680
   PubMed Web of Science ®Google Scholar
• Mihu MR, Sandkovsky U, Han G, Friedman JM, Nosanchuk JD, Martinez LR. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections. Virulence 2010; 1:62 - 7; http://dx.doi.org/10.4161/viru.1.2.10038; PMID: 21178416
   PubMed Web of Science ®Google Scholar
• Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis 2010; 51:79 - 84; http://dx.doi.org/10.1086/653120; PMID: 20504234
   PubMed Web of Science ®Google Scholar